Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Lung Ultrasound in Pediatric Acute Chest Syndrome

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Sickle-cell disease is a common disease with serious complications, in particular acute chest syndrome (ACS), which can be life threatening. The pathophysiology of ACS is poorly understood, but alveolar hypoventilation appears to play an important role. Pulmonary ultrasound is increasingly used in pediatrics to diagnose ACS. The management of ACS is complex, including oxygen therapy, antibiotics, spirometry, transfusions and ventilatory support. ACS and acute vaso-occlusive pain are the main reasons for hospitalisation in pediatric intensive care units. The aim of this study was to identify the pulmonary indicators correlated with ventilation time in these children, and to study the correlations between the results of lung ultrasound (LUS) and the clinical severity of the episode. The inclusion criteria for this study are the presence of an ACS in a child aged between 1 month and 17 years hospitalised in the pediatric intensive care unit at Robert-Debre Hospital who has not expressed any opposition and without opposition from their legal representative. The study will run for 2 years, with a target of 60 patients. Each patient included in the study will have multiple LUS during their care, in accordance with a protocol, and their clinical, biological and radiological data will be collected during their stay in the department.

Who May Be Eligible (Plain English)

Who May Qualify: - Sickle cell disease patient aged 1 month to 17 years - Hospitalisation in the PICU of Robert-Debre hospital - Suspicion of acute chest syndrome ACS - No objection from a legal representative or the child taken in by the doctor. Who Should NOT Join This Trial: - Refusal of parents - Delay between first LUS and initiation of ventilator support greater than 6 hours - Patient without social insurance Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Sickle cell disease patient aged 1 month to 17 years * Hospitalisation in the PICU of Robert-Debre hospital * Suspicion of acute chest syndrome ACS * No objection from a legal representative or the child taken in by the doctor. Exclusion Criteria: * Refusal of parents * Delay between first LUS and initiation of ventilator support greater than 6 hours * Patient without social insurance

Treatments Being Tested

PROCEDURE

lung ultrasound

lung ultrasound repeated according to protocol during the stay in the paediatric intensive care unit

Locations (1)

Robert Debré hOSPITAL
Paris, France